Search

everythinglearnresearchcommunity

for

Search:↓

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Leprosy is mainly contracted during infancy or childhood.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The symposium concluded that environmental factors significantly contribute to skin aging.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Most pediatric inpatients needed dermatology consultations for unspecified rashes and drug reactions, with varied treatments.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.

Patients often experience long-lasting changes to their hair after stem cell transplants.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Skin issues can indicate immune system problems.

Old hair follicles grew better when moved to a young environment.

The cream with plant components increased skin collagen and the hair tonic promoted hair growth in mice.